. . "248"^^ . "Asclepius" . . "Kardiovaskul\u00E1rn\u00ED onemocn\u011Bn\u00ED (KVO) na podklad\u011B ateroskler\u00F3zy jsou st\u00E1le \u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou nemocnosti a \u00FAmrtnosti v \u010Cesk\u00E9 republice i ve v\u011Bt\u0161in\u011B zem\u00ED sv\u011Bta. I kdy\u017E do\u0161lo v posledn\u00EDch 20 letech k v\u00FDznamn\u00E9mu rozvoji diagnostiky a l\u00E9\u010Dby KVO, velk\u00FD potenci\u00E1l z\u016Fst\u00E1v\u00E1 v jejich sekund\u00E1rn\u00ED, a p\u0159edev\u0161\u00EDm v prim\u00E1rn\u00ED prevenci. Ateroskler\u00F3za a jej\u00ED komplikace jsou preventabiln\u00ED a m\u011Bly by b\u00FDt hlavn\u00ED prioritou nejen ve zdravotnictv\u00ED, ale i pro celou spole\u010Dnost.Preventivn\u00ED kardiologie v kostce pod\u00E1v\u00E1 stru\u010Dn\u00E9 informace o historii kardiovaskul\u00E1rn\u00ED prevence u n\u00E1s i ve sv\u011Bt\u011B, o v\u00FDvoji nemocnosti a \u00FAmrtnosti na KVO, o z\u00E1kladn\u00EDch statistick\u00FDch pojmech kardiovaskul\u00E1rn\u00ED epidemiologie, o koncepci a priorit\u00E1ch sou\u010Dasn\u00E9 preventivn\u00ED kardiologie, kter\u00E1 je zalo\u017Eena na d\u016Fkazech z v\u011Bdeck\u00FDch studi\u00ED. Krom\u011B standardn\u00EDch rizikov\u00FDch faktor\u016F KVO jsou zm\u00EDn\u011Bny i dal\u0161\u00ED nekonven\u010Dn\u00ED rizikov\u00E9 faktory, psychosoci\u00E1ln\u00ED faktory, hormon\u00E1ln\u00ED substituce u \u017Een a postaven\u00ED zobrazovac\u00EDch metod v prevenci KVO. P\u0159edev\u0161\u00EDm stanoven\u00ED glob\u00E1ln\u00EDho kardiovaskul\u00E1rn\u00EDho rizika je hlavn\u00ED prioritou sou\u010Dasn\u00E9 preventivn\u00ED kardiologie, nebo\u0165 rozhoduje o spr\u00E1vn\u00E9m l\u00E9\u010Debn\u00E9m a preventivn\u00EDm postupu. Jsou uvedeny i dal\u0161\u00ED mo\u017Enosti predikce kardiovaskul\u00E1rn\u00EDho, event. kardiometabolick\u00E9ho rizika. Velk\u00E1 pozornost je v\u011Bnov\u00E1na dosud m\u00E1lo v klinick\u00E9 praxi akceptovan\u00FDm p\u0159edstadi\u00EDm nej\u010Dast\u011Bj\u0161\u00EDch KVO vznikl\u00FDch na podklad\u011B ateroskler\u00F3zy a diabetu 2. typu: preklinick\u00E1 ateroskler\u00F3za, prehypertenze (vysok\u00FD norm\u00E1ln\u00ED krevn\u00ED tlak) a prediabetes (hrani\u010Dn\u00ED la\u010Dn\u00E1 glykemie, poru\u0161en\u00E1 gluk\u00F3zov\u00E1 tolerance a kardiometabolick\u00FD syndrom). Pr\u00E1v\u011B v t\u011Bchto ran\u00FDch stadi\u00EDch poruch regulace krevn\u00EDho tlaku a metabolismu gluk\u00F3zy i lipid\u016F je mo\u017Eno za\u010D\u00EDt s \u00FA\u010Dinnou prevenc\u00ED arteri\u00E1ln\u00ED hypertenze, ateroskler\u00F3zy, KVO a diabetu 2. typu. V z\u00E1v\u011Bru monografi e jsou diskutov\u00E1ny dva nov\u00E9 p\u0159\u00EDstupy v prevenci: ot\u00E1zka polypillu a personalizovan\u00E9ho p\u0159\u00EDstupu v predikci, prevenci a l\u00E9\u010Db\u011B KVO."@cs . . "Kardiovaskul\u00E1rn\u00ED onemocn\u011Bn\u00ED (KVO) na podklad\u011B ateroskler\u00F3zy jsou st\u00E1le \u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou nemocnosti a \u00FAmrtnosti v \u010Cesk\u00E9 republice i ve v\u011Bt\u0161in\u011B zem\u00ED sv\u011Bta. I kdy\u017E do\u0161lo v posledn\u00EDch 20 letech k v\u00FDznamn\u00E9mu rozvoji diagnostiky a l\u00E9\u010Dby KVO, velk\u00FD potenci\u00E1l z\u016Fst\u00E1v\u00E1 v jejich sekund\u00E1rn\u00ED, a p\u0159edev\u0161\u00EDm v prim\u00E1rn\u00ED prevenci. Ateroskler\u00F3za a jej\u00ED komplikace jsou preventabiln\u00ED a m\u011Bly by b\u00FDt hlavn\u00ED prioritou nejen ve zdravotnictv\u00ED, ale i pro celou spole\u010Dnost.Preventivn\u00ED kardiologie v kostce pod\u00E1v\u00E1 stru\u010Dn\u00E9 informace o historii kardiovaskul\u00E1rn\u00ED prevence u n\u00E1s i ve sv\u011Bt\u011B, o v\u00FDvoji nemocnosti a \u00FAmrtnosti na KVO, o z\u00E1kladn\u00EDch statistick\u00FDch pojmech kardiovaskul\u00E1rn\u00ED epidemiologie, o koncepci a priorit\u00E1ch sou\u010Dasn\u00E9 preventivn\u00ED kardiologie, kter\u00E1 je zalo\u017Eena na d\u016Fkazech z v\u011Bdeck\u00FDch studi\u00ED. Krom\u011B standardn\u00EDch rizikov\u00FDch faktor\u016F KVO jsou zm\u00EDn\u011Bny i dal\u0161\u00ED nekonven\u010Dn\u00ED rizikov\u00E9 faktory, psychosoci\u00E1ln\u00ED faktory, hormon\u00E1ln\u00ED substituce u \u017Een a postaven\u00ED zobrazovac\u00EDch metod v prevenci KVO. P\u0159edev\u0161\u00EDm stanoven\u00ED glob\u00E1ln\u00EDho kardiovaskul\u00E1rn\u00EDho rizika je hlavn\u00ED prioritou sou\u010Dasn\u00E9 preventivn\u00ED kardiologie, nebo\u0165 rozhoduje o spr\u00E1vn\u00E9m l\u00E9\u010Debn\u00E9m a preventivn\u00EDm postupu. Jsou uvedeny i dal\u0161\u00ED mo\u017Enosti predikce kardiovaskul\u00E1rn\u00EDho, event. kardiometabolick\u00E9ho rizika. Velk\u00E1 pozornost je v\u011Bnov\u00E1na dosud m\u00E1lo v klinick\u00E9 praxi akceptovan\u00FDm p\u0159edstadi\u00EDm nej\u010Dast\u011Bj\u0161\u00EDch KVO vznikl\u00FDch na podklad\u011B ateroskler\u00F3zy a diabetu 2. typu: preklinick\u00E1 ateroskler\u00F3za, prehypertenze (vysok\u00FD norm\u00E1ln\u00ED krevn\u00ED tlak) a prediabetes (hrani\u010Dn\u00ED la\u010Dn\u00E1 glykemie, poru\u0161en\u00E1 gluk\u00F3zov\u00E1 tolerance a kardiometabolick\u00FD syndrom). Pr\u00E1v\u011B v t\u011Bchto ran\u00FDch stadi\u00EDch poruch regulace krevn\u00EDho tlaku a metabolismu gluk\u00F3zy i lipid\u016F je mo\u017Eno za\u010D\u00EDt s \u00FA\u010Dinnou prevenc\u00ED arteri\u00E1ln\u00ED hypertenze, ateroskler\u00F3zy, KVO a diabetu 2. typu. V z\u00E1v\u011Bru monografi e jsou diskutov\u00E1ny dva nov\u00E9 p\u0159\u00EDstupy v prevenci: ot\u00E1zka polypillu a personalizovan\u00E9ho p\u0159\u00EDstupu v predikci, prevenci a l\u00E9\u010Db\u011B KVO." . "Preventivn\u00ED kardiologie v kostce" . . "Baxa, Jan" . "99156" . "7"^^ . "248"^^ . . "Filipovsk\u00FD, Jan" . . "Preventivn\u00ED kardiologie v kostce"@cs . "7"^^ . . "Podlipn\u00FD, Ji\u0159\u00ED" . "Axonite CZ" . . . "Cardiovascular disease (CVD) on the basis of atherosclerosis is still the most frequent cause of morbidity and mortality in the Czech Republic and in most other countries around the world. Even though there has been a signifi cant increase in the development of diagnosis and treatment of cardiovascular diseases in the past 20 years, a large potential still remains in the secondary and especially in the primary prevention of CVD. Atherosclerosis and its complications are preventableddiseases and should be a top priority, not only in the fi eld of health care, but also for all of society in general.The monography provides concise information about the history of cardiovascular disease prevention in this country and abroad, the development of morbidity and mortality from CVD, basic statistics in terms of cardiovascular epidemiology, as well as concepts and priorities in current preventive cardiology based on evidence from scientifi research. In addition to standard cardiovascular risk factors, other unconventional risk factors such as psychosocial factors, hormone replacement therapy in women and the role of imaging methods in prevention of CVD are also discussed. First and foremost, global cardiovascular risk assessment is the main priority in current preventive cardiology as it is the deciding factor in establishing proper treatment and prevention. Close attention has been paid to, though up to now rarely accepted in clinical practice, pre-disease stages of the most common CVD incurred on the basis of atherosclerosis and Type 2 diabetes mellitus: preclinical atherosclerosis, pre-hypertension (high normal bloodpressure) and pre-diabetes (impaired fasting glucose, impaired glucose tolerance and cardio metabolic In the conclusion of this monograph two new trends in prevention have been presented; questioning the role of polypill, and using a personalised approach in the prediction, prevention and treatment of CVD."@en . "Preventivn\u00ED kardiologie v kostce" . "Preventivn\u00ED kardiologie v kostce"@cs . . "[DD54AE3C9239]" . . "RIV/00669806:_____/13:10144259!RIV14-MZ0-00669806" . "Praha" . "I" . "Preventivn\u00ED kardiologie v kostce" . . . "RIV/00669806:_____/13:10144259" . "Rosolov\u00E1, Hana" . . "978-80-904899-5-0" . . "Nussbaumerov\u00E1, Barbora" . "Mayer, Otto" . "Preventive Cardiology in a Nutshell"@en . . . "primary and secondary prevention; Cardiovascular disease"@en . . "Preventive Cardiology in a Nutshell"@en . . "Ferda, Ji\u0159\u00ED" .